FDA Approves First Drug for Neoadjuvant Breast Cancer Use

Published October 2, 2013

FDA Approves First Drug for Neoadjuvant Breast Cancer Use
The FDA's endorsement of pertuzumab comes under the agency's accelerated approval program. Confirmatory evidence from additional clinical trials will be needed eventually for … "We are seeing a significant shift in the treatment paradigm for early …
Read more on Medscape

ABAM Foundation receives M grant to establish Center for Physician Training …
The purpose of the new Center will be to expand the education and training of physicians in addiction medicine, with a special emphasis on prevention and screening, brief intervention and referral to treatment (SBIRT), particularly for adolescents and …
Read more on News-Medical.net

Why cancer treatment needn't mean the end of fertility
The procedure typically costs around $ 12,000; because it is experimental, research centers often provide funding, according to Teresa Woodruff, a professor of obstetrics and gynecology at the Feinberg School of Medicine at Northwestern University. “I …
Read more on Dallas Morning News